首页|同型半胱氨酸与帕金森病相关性的研究进展

同型半胱氨酸与帕金森病相关性的研究进展

扫码查看
帕金森病(Parkinson disease,PD)是老年人群中常见的神经系统退行性疾病,且当前医疗技术水平无法完全治愈,对患者的生存及生活质量造成不可忽视的影响,因此如何延缓PD的进展及改善预后成为当前亟待解决的问题.血浆同型半胱氨酸(homocysteine,Hcy)通过对血管内皮细胞、神经细胞和线粒体的影响及蛋白修饰机制,对PD患者神经系统造成损伤,与PD的严重程度的分期、临床症状和预后相关联.同时也对患者认知功能造成影响.临床通过补充叶酸和B族维生素等可有效降低Hcy.降低PD患者血浆Hcy水平将有利于延缓PD进展和改善PD的症状及预后.本文通过对近年国内外文献的分析综合,对PD和Hcy关系的具体机制进行综述,以期为临床治疗PD提供参考价值.
Research Progress on the Correlation between Homocysteine and Parkinson Disease
Parkinson disease(PD)is a common neurological degenerative disease in the elderly population,and the current level of medical technology can not completely cure it,which has an non-negligible impact on the survival and quality of life of patients,so how to delay the progress of PD and improve the prognosis has become an urgent problem to be solved.Plasma homocysteine(Hcy)can damage the nervous system of patients with PD through its effects on vascular endothelial cells,nerve cells and mitochondria and its protein modification mechanism,which is associated with the severity stage,clinical symptoms and prognosis of PD.At the same time,it also affects the cognitive function of patients.Clinical supplementation of folic acid and B vitamins can effectively reduce Hcy.Reducing plasma Hcy level in PD patients will help delay the progression of PD and improve the symptoms and prognosis of PD.Based on the analysis and synthesis of recent domestic and foreign literature,this paper reviews the specific mechanism of the relationship between PD and Hcy,in order to provide reference value for clinical treatment of PD.

Parkinson diseaseHomocysteineReview

赖洪萍、邵彩庆、黎锦标、孙冉

展开 >

济宁医学院临床医学院 山东 济宁 272067

济宁医学院附属医院神经内科 山东 济宁 272007

帕金森病 同型半胱氨酸 综述

济宁市重点研发计划

2021YXNS082

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(14)
  • 41